Denials are not simply billing problems. They are operational failures with direct financial consequences.
The 2026 oncology reimbursement environment represents one of the most operationally challenging periods oncology practices have faced in years.
A data-driven look at rising denial rates across private practices, healthcare organizations, and EMR-driven billing systems